EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Immunometabolic factors contributing to obesity-linked hepatocellular carcinoma

May G Akl, Scott B Widenmaier

Frontiers in Cell and Developmental Biology · 12.01.2023 · 10

DOI: 10.3389/fcell.2022.1089124 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 12.01.2023. Verfasst von May G Akl und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, Physiology, and Pharmacology, University of Saskatchewan, Saskatoon, SK, Canada. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 250 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) is a major public health concern that is promoted by obesity and associated liver complications. Onset and progression of HCC in obesity is a multifactorial process involving complex interactions between the metabolic and immune system, in which chronic liver damage resulting from metabolic and inflammatory insults trigger carcinogenesis-promoting gene mutations and tumor metabolism. Moreover, cell growth and proliferation of the cancerous cell, after initiation, requires interactions between various immunological and metabolic pathways that provide stress defense of the cancer cell as well as strategic cell death escape mechanisms. The heterogenic nature of HCC in addition to the various metabolic risk factors underlying HCC development have led researchers to focus on examining metabolic pathways that may contribute to HCC development. In obesity-linked HCC, oncogene-induced modifications and metabolic pathways have been identified to support anabolic demands of the growing HCC cells and combat the concomitant cell stress, coinciding with altered utilization of signaling pathways and metabolic fuels involved in glucose metabolism, macromolecule synthesis, stress defense, and redox homeostasis. In this review, we discuss metabolic insults that can underlie the transition from steatosis to steatohepatitis and from steatohepatitis to HCC as well as aberrantly regulated immunometabolic pathways that enable cancer cells to survive and proliferate in the tumor microenvironment. We also discuss therapeutic modalities targeted at HCC prevention and regression. A full understanding of HCC-associated immunometabolic changes in obesity may contribute to clinical treatments that effectively target cancer metabolism.

Schlagwörter

Stichwörter der Autor:innen

NAFLDhepatocellular carcinoma (HCC)immunometabolismobesitystress pathways

Autor:innen und Institutionen

  • Department of Anatomy, Physiology, and Pharmacology, University of Saskatchewan, Saskatoon, SK, Canada.
  • Department of Physiology, University of Alexandria, Alexandria, Egypt.

Zitieren

APA

Akl, M. G., & Widenmaier, S. B. (2023). Immunometabolic factors contributing to obesity-linked hepatocellular carcinoma. Frontiers in Cell and Developmental Biology, 10. https://doi.org/10.3389/fcell.2022.1089124

Vancouver

Akl MG, Widenmaier SB. Immunometabolic factors contributing to obesity-linked hepatocellular carcinoma. Frontiers in Cell and Developmental Biology. 2023;10. doi:10.3389/fcell.2022.1089124

BibTeX
@article{Akl2023,
  author = {Akl, May G and Widenmaier, Scott B},
  title = {Immunometabolic factors contributing to obesity-linked hepatocellular carcinoma},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2023},
  volume = {10},
  doi = {10.3389/fcell.2022.1089124}
}
Kostenlos starten →